IBI-Ag’s products represent a fundamental departure from conventional crop protection chemistry. Rather than relying on broad-spectrum toxins, our bioinsecticides are built on protein-based active ingredients, engineered to bind with precision to specific target proteins within the insect, disrupting essential biological functions with minimal off-target effects.
Our development pipeline includes products derived from both our nanobody platform and our AI De Novo protein design platform, targeting a range of economically significant insect pests across multiple crop categories.
Products Attributes
Novel Mode of Action
IBI-Ag’s bioinsecticides operate through a mechanism not currently represented in the market, reducing the risk of cross-resistance with existing insecticide classes.
Environmentally Compatible
Naturally derived protein-based active ingredients leave minimal environmental traces. Suitable for use in integrated pest management (IPM) programs and organic agriculture contexts.
Target Selective
Designed to target specific pest species, reducing impact on non-target organisms including beneficial insects such as bees and other pollinators.
Low Residue
Designed for short term efficacy reducing residues on the crop and shortening time from spray to harvest.
Favorable Regulatory Profile
Protein-based biopesticides are considered a bio-chemicals with a shorter regulatory pathway compared to synthetic chemistry, supporting faster routes to market in key geographies.
Two Generations. One Mission.
IBI-Ag develops two generations of precision bioinsecticides, proven today, and engineered for tomorrow.
Nanobody-Based Products
Our first-generation products are nanobody-based bioinsecticides, single domain antibodies developed in vivo, with a validated proprietary target library and demonstrated efficacy against key insect pest species.
AI De Novo Design Platform
Our second generation takes this foundation further, leveraging state-of-the-art computational AI and our proprietary IP to design de novo bioinsecticide proteins, faster, broader, and against targets previously out of reach.